Biliary and gallbladder problems associated with using Ozempic, Wegovy, and Mounjaro include Cholecystitis and Cholelithiasis (gallstones)
It is also consistent with a small clinical trial study of the GLP-1RA drug exenatide, which significantly reduced heavy drinking days and total alcohol intake in patients with obesity 12 and with a register-based study in Demark showing that GLP-1RAs (though semaglutide was not included) compared with dipeptidyl peptidase 4 inhibitors (DPP4) were associated with lower incidence of alcohol-related events in 20092017 13
It is responsible for numerous crucial functions, including growth, cell production, tissue building and repair, muscle building, and even brain function
It also helps lower something called oxidized LDL, which is linked to hardening of the arteries
LY3298176, a Novel Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus: From Discovery to Clinical Proof of Concept